IONIS PHARMACEUTICALS INC — Director's Dealing 2020

Sep 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-09-16

Reporting Person: WENDER JOSEPH H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-16	Common Stock	M	11250.0	$12.94	Acquired	77055	Indirect
2020-09-16	Common Stock	M	11250	$28.47	Acquired	88305	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-16	Director Stock Option (right to buy)	$12.94	M	11250.0	Disposed	2022-07-01	Common Stock (11250.0)	Direct
2020-09-16	Director Stock Option (right to buy)	$28.47	M	11250	Disposed	2023-06-30	Common Stock (11250)	Direct

Footnotes

F1: Acquired as a result of exercising a stock option.